The harmful or hazardous use of psychoactive substances, measured on a clinical spectrum rather than judged as a moral failure.
The language around drug use is broken. Public discourse treats “substance abuse” as a character flaw, a failure of willpower, or a criminal act. The word “abuse” itself implies culpability: someone is doing something wrong, not something that is happening to them. This framing persists despite decades of clinical evidence that substance use disorders are medical conditions with identifiable neurobiological, genetic, and environmental drivers. The moralised lens does not just misdescribe the problem. It actively obstructs treatment by generating stigma, deterring people from seeking help, and channelling policy toward punishment rather than prevention.
Clinically, the field has moved on. The DSM-5 (2013) collapsed the old DSM-IV categories of “substance abuse” and “substance dependence” into a single diagnosis: Substance Use Disorder (SUD). The reason was empirical. Factor analyses across more than 200,000 study participants showed that the old abuse and dependence criteria loaded onto a single underlying dimension, not two distinct conditions (Hasin et al. 2013). SUD is now measured on a severity continuum: mild (2 to 3 of 11 criteria), moderate (4 to 5), or severe (6 or more). The 11 criteria span four domains: impaired control, social impairment, risky use, and pharmacological symptoms (tolerance and withdrawal). The WHO’s ICD-11 follows a parallel logic, distinguishing episodic harmful use, harmful patterns of use, and substance dependence as points on a spectrum rather than discrete boxes.
The public health framing matters because it reshapes what “substance abuse” actually means in practice. WHO defines it as the harmful or hazardous use of psychoactive substances, including alcohol and illicit drugs, that produces negative health consequences and social burden (WHO, 2024). This is not a lifestyle critique. It is a description of a condition that interacts with poverty, trauma, mental health comorbidity, and social exclusion. The shift from “abuse” to “use disorder” is not just terminological housekeeping. It reflects a fundamental reorientation: from blaming the person to mapping the condition, from moral judgment to clinical severity, from a binary of clean versus dirty to a gradient where early intervention is possible before crisis point. The essay’s observation that some substances erode capacity slowly, fraction by fraction, maps precisely onto the mild end of this spectrum, the zone where people are most likely to be told they do not have a “real problem.”